Alzheimer’s

Six in 10 people living with the Alzheimer's disease will wander off at some point.

The legislation creates optional training for police on recognizing someone with dementia, communicating with them, using alternatives to physical restraints, and spotting abuse,

“Music and Mind" is a collection of essays by scientists, artists, educators and health care providers that delves into the effect of music and the arts on health and being human.

FDA approval is required to make Alzheimer's biomarker testing affordable, but a brain specialist is needed to make an accurate diagnosis.

The disease requires a brain scan or spinal tap to spot one sticky amyloid protein. But a recent study finds that a certain blood test helped improve diagnosis without more costly follow-up procedures.

The GUIDE Model is designed to facilitate comprehensive, coordinated care that improves the quality of life for people with dementia and reduces the strain on their unpaid caregivers.

The FDA approved donanemab, which will be sold under the brand name Kisunla. The new drug helps slow decline in Alzheimer's patients with mild cognitive impairment.

President Joe Biden is under pressure to undergo cognitive testing even though his physician says he passes an annual neurologic exam. But what can the brief screening tool actually tell about a person’s brain health?

The clinic will provide two medications that can slow the progression of the disease in early stages: Leqembi and Kisunla. The Roskamp Institute plans to open the facility in September.

A 2023 Alzheimer's Association report notes that 70% of caregivers say coordinating care is stressful. Three out of four say they are concerned for their own health given the stress and difficulty of the job.